Therefore, this application of QuPath to quantify the percentage of BCL2A1-positive cells in the EPM has paved the way for the objective assessment of the intensity related to neutrophils infiltrating the EPM regions where acute HCA was most advanced in addition to the staging of acute HCA in the EPM. The gene discussed is BCL2A1; the disease is hepatocellular adenoma.